Alvogen has launched the first generic equivalent of multiple sclerosis treatment Copaxone in Europe, with the product said to "provide an affordable high quality alternative to MS patients".
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 07 Sep 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Sep 16
